Arbutus Biopharma (STU:I9DN) Marketable Securities : €79.25 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Arbutus Biopharma Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Arbutus Biopharma's Marketable Securities for the quarter that ended in Mar. 2024 was €79.25 Mil.

Arbutus Biopharma's annual Marketable Securities increased from Dec. 2021 (€40.74 Mil) to Dec. 2022 (€109.63 Mil) but then declined from Dec. 2022 (€109.63 Mil) to Dec. 2023 (€91.44 Mil).

Arbutus Biopharma Marketable Securities Historical Data

The historical data trend for Arbutus Biopharma's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arbutus Biopharma Marketable Securities Chart

Arbutus Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

53.13

58.38

40.74

109.63

91.44

Arbutus Biopharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															99.15	115.64	109.30	91.44	79.25

Arbutus Biopharma Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Arbutus Biopharma (STU:I9DN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Arbutus Biopharma Marketable Securities Related Terms

Thank you for viewing the detailed overview of Arbutus Biopharma's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Arbutus Biopharma (STU:I9DN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arbutus Biopharma Corp (STU:I9DN) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

ABUS:USA

Address

701 Veterans Circle, Warminster, PA, USA, 18974

Website

http://www.arbutusbio.com

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

Arbutus Biopharma (STU:I9DN) Headlines

No Headlines